Host Inactivation of Bacterial Lipopolysaccharide Prevents Prolonged Tolerance Following Gram-Negative Bacterial Infection

Cell Host and Microbe

Volumn 4, Issue 3, 2008, Pages 293-302

  Lu, Mingfang ^a   Varley, Alan W ^a   Ohta, Shoichiro ^b   Hardwick, John ^a   Munford, Robert S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SAGA UNIVERSITY   (Japan)

Author keywords

MICROBIO; MOLIMMUNO

Indexed keywords

ACYLOXYACYL HYDROLASE; BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENZYME DEFICIENCY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFECTION RESISTANCE; INFECTION SENSITIVITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; CARBOXYLIC ESTER HYDROLASES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA;

EID: 50849107371     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2008.06.009     Document Type: Article

References (68)

1. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll- like receptor 3. Nature 413 (2001) 732-738
2. Bagchi A., Herrup E.A., Warren H.S., Trigilio J., Shin H.S., Valentine C., and Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178 (2007) 1164-1171
3. Bates J.M., Akerlund J., Mittge E., and Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2 (2007) 371-382
4. Beumer C., Wulferink M., Raaben W., Fiechter D., Brands R., and Seinen W. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307 (2003) 737-744
5. Björkbacka H., Fitzgerald K.A., Huet F., Li X., Gregory J.A., Lee M.A., Ordija C.M., Dowley N.E., Golenbock D.T., and Freeman M.W. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol. Genomics 19 (2004) 319-330
6. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
7. Cavaillon J.M., Adrie C., Fitting C., and Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance?. J. Endotoxin Res. 9 (2003) 101-107
8. Chen H., Cowan M.J., Hasday J.D., Vogel S.N., and Medvedev A.E. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-{kappa}B in Alveolar macrophages stimulated with TLR2 and TLR4 agonists. J. Immunol. 179 (2007) 6097-6106
9. Cross A.S. Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8 (2002) 83-98
10. Cross A., Asher L., Seguin M., Yuan L., Kelly N., Hammack C., Sadoff J., and Gemski Jr. P. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J. Clin. Invest. 96 (1995) 676-686
11. Deng J.C., Cheng G., Newstead M.W., Zeng X., Kobayashi K., Flavell R.A., and Standiford T.J. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116 (2006) 2532-2542
12. Didierlaurent A., Goulding J., Patel S., Snelgrove R., Low L., Bebien M., Lawrence T., van Rijt L.S., Lambrecht B.N., Sirard J.C., and Hussell T. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205 (2008) 323-329
13. Dobrovolskaia M.A., Medvedev A.E., Thomas K.E., Cuesta N., Toshchakov V., Ren T., Cody M.J., Michalek S.M., Rice N.R., and Vogel S.N. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J. Immunol. 170 (2003) 508-519
14. Echtenacher B., and Mannel D.N. Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. J. Endotoxin Res. 8 (2002) 365-369
15. Engelhardt R., Mackensen A., and Galanos C. Phase I Trial of Intravenously Administered Endotoxin (Salmonella abortus equi) in Cancer Patients. Cancer Res. 51 (1991) 2524-2530
16. Faist E., Mewes A., Strasser T., Walz A., Alkan S., Baker C., Ertel W., and Heberer G. Alteration of monocyte function following major injury. Arch. Surg. 123 (1988) 287-292
17. Feterowski C., Weighardt H., Emmanuilidis K., Hartung T., and Holzmann B. Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur. J. Immunol. 31 (2001) 1268-1277
18. Feulner J.A., Lu M., Shelton J.M., Zhang M., Richardson J.A., and Munford R.S. Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract. Infect. Immun. 72 (2004) 3171-3178
19. Fitting C., Dhawan S., and Cavaillon J. Compartmentalization of Tolerance to Endotoxin. J. Infect. Dis. 189 (2004) 1295-1303
20. Foster S.L., Hargreaves D.C., and Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447 (2007) 972-978
21. Freudenberg M.A., and Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56 (1988) 1352-1357
22. Freudenberg M.A., Merlin T., Gumenscheimer M., Kalis C., Landmann R., and Galanos C. Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria. Microbes Infect. 3 (2001) 1213-1222
23. Galanos C., Luderitz O., and Westphal O. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9 (1969) 245-249
24. Gao L., Tsai Y.J., Grigoryev D.N., and Barnes K.C. Host defense genes in asthma and sepsis and the role of the environment. Curr. Opin. Allergy Clin. Immunol. 7 (2007) 459-467
25. Greisman S.E., Hornick R.B., Carozza Jr. F.A., and Woodward T.E. The role of endotoxin during typhoid fever and tularemia in man. I. Acquisition of tolerance to endotoxin. J. Clin. Invest. 42 (1963) 1064-1075
26. Greisman S.E., Young E.J., and Carozza Jr. F.A. Mechanisms of Endotoxin Tolerance: V. Specificity of the early and late phases of pyrogenic tolerance. J. Immunol. 103 (1969) 1223-1236
27. He T.-C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95 (1998) 2509-2514
28. Hedl M., Li J., Cho J.H., and Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. USA 104 (2007) 19440-19445
29. Helminen M., and Vesikari T. Increased interleukin-1 (IL-1) production from LPS-stimulated peripheral blood monocytes in children with febrile convulsions. Acta Paediatr. Scand. 79 (1990) 810-816
30. Helminen M., and Vesikari T. Interleukin-1 production in bacterial meningitis. Scand. J. Infect. Dis. 22 (1990) 105-108
31. Henricson B.E., Manthey C.L., Yu Perera P., Hamilton T.A., and Vogel S.N. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61 (1993) 2325-2333
32. Ingraham J.L., Maaloe O., and Neidhardt F.C. Growth of the Bacterial Cell (1983), Sinauers Associates, Inc., Sunderland, MA
33. Kelly J.L., O'Sullivan C., O'Riordain M., O'Riordain D., Lyons A., Doherty J., Mannick J.A., and Rodrick M.L. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury. Ann. Surg. 225 (1997) 530-541
34. Kitamura D., Roes J., Kuhn R., and Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350 (1991) 423-426
35. Koyama I., Matsunaga T., Harada T., Hokari S., and Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35 (2002) 455-461
36. Lehner M.D., Ittner J., Bundschuh D.S., Van Rooijen N., Wendel A., and Hartung T. Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect. Immun. 69 (2001) 463-471
37. Lu M., Zhang M., Kitchens R.L., Fosmire S., Takashima A., and Munford R.S. Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J. Exp. Med. 197 (2003) 1745-1754
38. Lu M., Zhang M., Takashima A., Weiss J., Apicella M.A., Li X.H., Yuan D., and Munford R.S. Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat. Immunol. 6 (2005) 989-994
39. Mason C.M., Dobard E., Summer W.R., and Nelson S. Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J. Infect. Dis. 176 (1997) 1293-1302
40. Mata-Haro V., Cekic C., Martin M., Chilton P.M., Casella C.R., and Mitchell T.C. The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4. Science 316 (2007) 1628-1632
41. McCabe W.R. Endotoxin tolerance. II. Its occurrence in patients with pyelonephritis. J. Clin. Invest. 42 (1963) 618-625
42. McCall C.E., and Yoza B.K. Gene silencing in severe systemic inflammation. Am. J. Respir. Crit. Care Med. 175 (2007) 763-767
43. McCall C.E., Grosso-Wilmoth L.M., LaRue K., Guzman R.N., and Cousart S.L. Tolerance to endotoxin-induced expression of the interleukin- 1β gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91 (1993) 853-861
44. Medvedev A.E., Sabroe I., Hasday J.D., and Vogel S.N. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin Res. 12 (2006) 133-150
45. Munford R.S. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?. Infect. Immun. 76 (2008) 454-465
46. Munford R.S., and Hall C.L. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234 (1986) 203-205
47. Munford R.S., and Erwin A.L. Eucaryotic lipopolysaccharide deacylating enzyme. Methods Enzymol. 209 (1992) 485-492
48. Munford R.S., and Varley A.W. Shield as signal: lipopolysaccharides and the evolution of immunity to Gram-negative bacteria. PLoS Pathog. 2 (2006) e67
49. Munford R.S., DeVeaux L.C., Cronan Jr. J.E., and Rick P.D. Biosynthetic radiolabeling of bacterial lipopolysaccharide to high specific activity. J. Immunol. Methods 148 (1992) 115-120
50. Munoz C., Carlet J., Fitting C., Misset B., Bieriot J.-P., and Cavaillon J.-M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88 (1991) 1747-1754
51. Ohta S., Bahrun U., Shimazu R., Matsushita H., Fukudome K., and Kimoto M. Induction of Long-Term Lipopolysaccharide Tolerance by an Agonistic Monoclonal Antibody to the Toll-Like Receptor 4/MD-2 Complex. Clin. Vaccine Immunol. 13 (2006) 1131-1136
52. Palmer D., and Ng P. Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8 (2003) 846-852
53. Parks R.J., Chen L., Anton M., Sankar U., Rudnicki M.A., and Graham F.L. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 93 (1996) 13565-13570
54. Peterson A.A., and Munford R.S. Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infect. Immun. 55 (1987) 974-978
55. Poelstra K., Bakker W.W., Klok P.A., Hardonk M.J., and Meijer D.K.F. A physiologic function for alkaline phosphatase: Endotoxin detoxification. Lab. Invest. 76 (1997) 319-327
56. Sato S., Takeuchi O., Fujita T., Tomizawa H., Takeda K., and Akira S. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and - independent pathways. Int. Immunol. 14 (2002) 783-791
57. Shao B., Lu M., Katz S.C., Varley A.W., Hardwick J., Rogers T.E., Ojogun N., Rockey D.C., DeMatteo R.P., and Munford R.S. A Host Lipase Detoxifies Bacterial Lipopolysaccharides in the Liver and Spleen. J. Biol. Chem. 282 (2007) 13726-13735
58. Shnyra A., Brewington R., Alipio A., Amura C., and Morrison D.C. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J. Immunol. 160 (1998) 3729-3736
59. Somerville Jr. J.E., Cassiano L., Bainbridge B., Cunningham M.D., and Darveau R.P. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Invest. 97 (1996) 359-365
60. Tobias P.S., Soldau K., Gegner J.A., Mintz D., and Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270 (1995) 10482-10488
61. Vaishnava S., and Hooper L.V. Alkaline phosphatase: keeping the peace at the gut epithelial surface. Cell Host Microbe 2 (2007) 365-367
62. van Veen S.Q., van Vliet A.K., Wulferink M., Brands R., Boermeester M.A., and van Gulik T.M. Bovine Intestinal Alkaline Phosphatase Attenuates the Inflammatory Response in Secondary Peritonitis in Mice. Infect. Immun. 73 (2005) 4309-4314
63. Von Baehr V., Döcke W.D., Plauth M., Liebenthal C., Küpferling S., Lochs H., Baumgarten R., and Volk H.D. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 47 (2000) 281-287
64. Wang J.H., Doyle M., Manning B.J., Blankson S., Wu Q.D., Power C., Cahill R., and Redmond H.P. Bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J. Immunol. 170 (2003) 14-18
65. Weighardt H., Heidecke C.D., Emmanuilidis K., Maier S., Bartels H., Siewert J.R., and Holzmann B. Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery 127 (2000) 309-315
66. West M.A., and Heagy W. Endotoxin tolerance: A review. Crit. Care Med. 30 (2002) S64-S73
67. Wysocka M., Robertson S., Riemann H., Caamano J., Hunter C., Mackiewicz A., Montaner L.J., Trinchieri G., and Karp C.L. IL-12 suppression during experimental endotoxin tolerance: Dendritic cell loss and macrophage hyporesponsiveness. J. Immunol. 166 (2001) 7504-7513
68. Wysocka M., Montaner L.J., and Karp C.L. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis. J. Immunol. 174 (2005) 7398-7402